In a week when referral fees dominated the headlines, we also reported on another Solvency II setback, Oxygen's road to recovery and mused on how Aviva might splash its cash
We’re glad you’ve chosen Insurance Times as your source for industry news and hope you’ve been enjoying reading articles from our award-winning team of journalists.
Gain access to more of our exclusive, breaking stories, interviews and news analysis as it happens. Registering is quick, easy, free, and will also have the additional benefits:
As a subscriber you will benefit from unlimited access to our news and news analysis, magazine editions, special supplements, exclusive research reports and full access to the Five Star service rating microsites - view subscription options.